Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01959022 · ClinicalTrials.gov registry record · Phase 4
A Pilot Study to Assess the Effects of Doxazosin on Polysomnography in PTSD
A Phase 4 study, sponsored by San Francisco Veterans Affairs Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 15
- Enrollment target
NCT01959022 is a Phase 4 study that has completed, run by San Francisco Veterans Affairs Medical Center. The registered enrollment target is 15 participants.
The verdict
NCT01959022, a Phase 4 study, has completed, sponsored by San Francisco Veterans Affairs Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 15 participants
- Enrollment target
Study Summary
This study will assess the effects of the medication doxazosin on sleep in men and women with PTSD. Sleep will be measured objectively at home using a portable sleep recorder and wrist actigraphy.
Interventions
- DRUG Doxazosin XL
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2013-10 |
| Est. Completion | 2016-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01959022
The ClinicalTrials.gov registry entry for NCT01959022 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is San Francisco Veterans Affairs Medical Center, which has 15 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Doxazosin XL is the first listed.
NCT01959022 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01959022 about?
NCT01959022 is a clinical study titled "A Pilot Study to Assess the Effects of Doxazosin on Polysomnography in PTSD". This study will assess the effects of the medication doxazosin on sleep in men and women with PTSD. Sleep will be measured objectively at home using a portable sleep recorder and wrist actigraphy.
What is the current status of trial NCT01959022?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 15 participants. The study started on 2013-10. Estimated completion is 2016-06.
What interventions are being tested in trial NCT01959022?
The interventions under investigation include: Doxazosin XL (DRUG).
Who is sponsoring clinical trial NCT01959022?
This trial is sponsored by San Francisco Veterans Affairs Medical Center, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.